Skip to main content

ICMAD Stresses Need for Uniform Cosmetics Industry Standards

Pamela J. Busiek, chief executive officer of ICMAD, stressed the need for uniform standards between retailers and regulatory agencies at the Global Retailers and Manufacturers Alliance (GRMA) meeting in Ann Arbor, Mich.

Pamela J. Busiek, chief executive officer of The Independent Cosmetic Manufacturers and Distributors (ICMAD), stressed the vital need for uniform standards between retailers and regulatory agencies to strengthen safety, quality and trust throughout the supply chain at the Global Retailers and Manufacturers Alliance (GRMA) meeting in Ann Arbor, Mich.,on Monday.

Busiek shared a variety of ongoing efforts to reform cosmetics regulation, including the recently introduced Personal Care Products Safety Act, introduced in April by U.S. Senators Dianne Feinstein (D-Calif.) and Susan Collins (R-Maine). While the personal-care products industry is projected to exceed $60 billion in U.S. revenue this year, federal regulations on these products have not been updated in 75 years.

“The cosmetic business historically has afforded entrepreneurs with opportunities that they have translated from startups to multimillion-dollar, multinational businesses, generating thousands of jobs and industry breakthroughs,” Busiek said. She cited Revlon, which funded medical device development including contact lenses, and Clairol, which contributed to funding important cancer treatments.

“ICMAD has a long track record of working with industry experts and federal regulators to promote product safety, honor the best science in our industry, and advance small businesses that innovate and provide jobs,” continued Busiek. “The work of the GRMA on developing relevant, consensus-based standards will help ensure our industry continues to have viable contributors.”

You May Also Like

The GRMA is a joint initiative with global public health organization NSF International, an ICMAD partner, established in 2014 to develop consensus-based standards for dietary supplements, cosmetics and personal-care products, over-the-counter drugs and devices.